pharma · Advanced Gastric or Gastroesophageal Junction Cancer · Dwarfism
GeneScience Pharmaceuticals Co
Changchun GeneScience Pharmaceutical Co.,
Changchun GeneScience Pharmaceutical is a pharma organization headquartered in CN. Primary therapeutic focus areas include Advanced Gastric or Gastroesophageal Junction Cancer, Dwarfism, Growth Hormone Deficiency. NovaPh
CN HQ
30 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 30
- Programs
- 3
- Drugs
- 4
- Patents
- 0
Gentuximab
Phase 2 · small molecule · Advanced Gastric or Gastroesophageal Junction Cancer
Gentuximab for Advanced Gastric or Gastroesophageal Junction Cancer is a Phase 2 program (small_molecule) at Changchun GeneScience Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).
Internal code GenSci 043 CT
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Changchun GeneScience Pharmaceutical Co.,
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Advanced Gastric or Gastroesophageal Junction Cancer
- Status
- completed
- Trials
- 1